Statistical Parametric Mapping in Amyloid Positron Emission Tomography

Alzheimer’s disease (AD), the most common cause of dementia, has limited treatment options. Emerging disease modifying therapies are targeted at clearing amyloid-β (Aβ) aggregates and slowing the rate of amyloid deposition. However, amyloid burden is not routinely evaluated quantitatively for purpos...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Natasha M., Ford, Jeremy N., Haghdel, Arsalan, Glodzik, Lidia, Li, Yi, D’Angelo, Debra, RoyChoudhury, Arindam, Wang, Xiuyuan, Blennow, Kaj, de Leon, Mony J., Ivanidze, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083453/
https://www.ncbi.nlm.nih.gov/pubmed/35547630
http://dx.doi.org/10.3389/fnagi.2022.849932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083453/
https://www.ncbi.nlm.nih.gov/pubmed/35547630
http://dx.doi.org/10.3389/fnagi.2022.849932

Ejemplares similares